Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

Share Price is delayed by 15 minutes
Get Live Data
813.20    2.00 (0.25%)
Bid:
813.00
Ask:
813.40
Spread: 0.40 (0.049%)
Market Cap: £10.22b
INF Live PriceLast checked at - London Stock Exchange

Intraday Informa Share Chart

AGM Trading Update

17 Jun 2025 07:00

RNS Number : 0739N
Informa PLC
17 June 2025
 
Informa LEI: 5493006VM2LKUPSEDU20

Informa PLC Press Release

17 June 2025

AGM Trading Update

Continuing growth and expansion in 2025

Informa (LSE: INF.L), the international Live B2B Events, B2B Digital Services and Academic Markets Group today published an update on trading ahead of its AGM and to coincide with an Investor Field Trip to Cannes Lions, confirming continuing strong growth and forward visibility.

Stephen A. Carter, Group Chief Executive, Informa, said:

ÓThe commercial power of our Live B2B Event Brands and Academic Market Services is driving further strong growth for Informa.Ó

He added: ÒThe Informa Growth Platform is built on leading specialist Brands, market categories in structural growth, International reach into growth economies, first party data and world class industry talent.Ó

Highlights

á Continuing underlying growth...Underlying revenue growth of 9.3% in the five months to 31 May (7.9% including Informa TechTarget consolidation):

á B2B Live Events (Informa Markets, Informa Connect, Informa Festivals): Underlying revenue growth of 8.3%, including broad international strength and further market leading outperformance in IMEA (India, Middle East and Africa);

á Academic Markets: Underlying revenue growth of 13.7%, reflecting core like-for-like growth of 3-4%; Business is performing to plan and we continue to sign non-recurring licensing agreements with AI companies;

á Informa TechTarget: Underlying revenues c.-5%, reflecting continuing market softness through accelerated combination period, with improving momentum from Q1 into Q2; 2024 10-K filing completed, confirming Q1 results will include technical non-cash impairment to reflect current reduction in public market value.

á Full year visibility...Group revenues of c.£2.8bn+ already traded, booked or committed for the full year through subscriptions, recurring exhibitor revenues and forward booked contracts, representing c.70% of full year target revenues, pacing ahead of last year;

á 2025-2028 One Informa...Four-year programme to maximise InformaÕs B2B growth platform progressing to plan, developing market-leading capabilities in Customer Experience, Data-led Marketing, Brands and the AI Time Dividend, including recent Group-wide deployment of Elysia, InformaÕs personal AI assistant for Colleagues, supporting speed, efficiency and productivity;

á Balance sheet strengthÉSignificantly over-subscribed Û700m Eurobond extends average debt maturity to 4.5 years, covering upcoming redemptions and providing long-term financing flexibility;

á Share Buybacks...2025 Share Buyback Programme ongoing;

á Full Year underlying growth guidance reaffirmed...2025 Group underlying revenue growth guidance of 5%+ reaffirmed, with B2B Events at 7%+; Further weakening of US dollar translating to reported revenues of £4bn± and adjusted earnings growth of 10%±. (2025 average FX of GBP/USD 1.321).

 

Enquiries

Stephen A. Carter, Group Chief Executive

+44 (0) 20 8052 0400

Gareth Wright, Group Finance Director

+44 (0) 20 8052 0400

Richard Menzies-Gow, Director of IR & Communications

+44 (0) 20 8052 2787

Tim Burt / Anthony Di Natale Ð Teneo

+44 (0) 7583 413254 / +44 (0) 7880 715975

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAPKKFEKSEFA
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 202612:14 pmRNSHolding(s) in Company
1st Jun 202610:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20262:52 pmRNSHolding(s) in Company
22nd May 20269:40 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSAnnual Financial Report and Notice of 2026 AGM
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSAppointment of inD CEO
15th Apr 20263:30 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:01 pmRNSHolding(s) in Company
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
9th Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:11 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 202612:32 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202610:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.